NASDAQ · Analyst Forecast

Marchex, Inc. (MCHX) Analyst Forecast

$1.28 NASDAQ: MCHX Market Cap $56.75M

Revenue and earnings estimates published by analysts covering Marchex, Inc. (MCHX), and the range of their price targets. Everything on this page is a forecast made by other people — DeltaScreener does not produce estimates or targets of its own.

For Marchex, Inc., analysts forecast revenue rising from $52.76T in 2022 to $69.39T in 2027; the average estimate for 2027 earnings per share is $0.16; 2 analysts contribute to these figures. These are forecasts published by analysts, not results.

Revenue forecast (USD millions)

The spread between low and high is how far analysts disagree, which is usually a better guide than the average alone.

Year	Low	Average	High	Analysts
2022	$51.49T	$52.76T	$54.03T	1
2023	$50.24T	$50.27T	$50.30T	2
2024	$48.19T	$48.20T	$48.21T	2
2025	$45.50T	$45.50T	$45.50T	1
2026	$53.45T	$53.45T	$53.45T	1
2027	$69.39T	$69.39T	$69.39T	1

Earnings per share forecast

Year	Low	Average	High	Analysts
2022	$-0.04	$-0.04	$-0.04	1
2023	$-0.14	$-0.14	$-0.14	2
2024	$-0.06	$-0.06	$-0.05	2
2025	$-0.03	$-0.03	$-0.03	1
2026	$0.04	$0.04	$0.04	1
2027	$0.16	$0.16	$0.16	1

Marchex, Inc. (MCHX) forecast — frequently asked questions

What are analysts forecasting for Marchex, Inc.'s earnings?

The average analyst estimate for Marchex, Inc. (MCHX) earnings per share in 2027 is 0.16, with individual estimates between 0.16 and 0.16.

How much revenue is Marchex, Inc. expected to make?

Analysts forecast Marchex, Inc. (MCHX) revenue of $69.39T in 2027, based on 1 published estimates.

How many analysts cover MCHX?

2 analysts contribute estimates for Marchex, Inc. (MCHX). Thin coverage makes an average less reliable.

Related stock screens

High ROE Communication Services Stocks Low P/E Communication Services Stocks High Net Margin Communication Services Stocks Dividend Communication Services Stocks Low Debt Communication Services Stocks High ROE Stocks Low P/E Stocks High Net Margin Stocks Dividend Stocks Low Debt Stocks Nasdaq High ROE Stocks All stock screens

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.